Estou estudando a empresa, e observei o recente aumento de dívida com comprometimento das receitas. Achei o seguinte trecho em uma notícia
"In October, Abbott completed its acquisition of diagnostics firm Alere Inc. for $51 per share, or $5.3 billion in equity value. And in January of last year, Abbott wrapped up its $33 billion purchase of St. Jude Medical Inc., a maker of heart-failure devices and technology.
"[We] were up to a gross $28 billion of debt because of our acquisitions of St. Jude and Alere and a little bit of lingering debt we had just over time," White said on the call."
Se o foco da empresa for sanar esta dívida de aquisição, fica interessante!